Search results
Affordable health care is on the ballot in November
The Hill· 1 day ago“Low Insulin pricing was gotten for millions of Americans by me,” Donald Trump recently declared on Truth Social, his social media platform. Trump’s...
Final Section 1557 Rules: Highlights for Health Plan Sponsors | JD Supra
JD Supra· 5 days agoThe U.S. Department of Health and Human Services (HHS) has issued final regulations on the nondiscrimination rules set forth in Section 1557 of the Affordable Care Act. The new rules apply to ...
Gateway - Quartz
Quartz· 7 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...
Medicare Advantage Star Ratings proposal targets top performers
Modern Healthcare· 7 days agoAt issue is what's known as the "hold harmless" policy. Medicare Advantage contracts that earn at least 4 out of 5 stars can choose to disregard two highly weighted “quality improvement” elements ...
Letter: We need alternatives to opioids
Bangor Daily News· 4 days agoAs a retired millworker, I have witnessed the devastating impact of the opioid crisis on mill towns throughout Maine and communities around the entire...
Gateway - Quartz
Quartz· 6 days agoCenters for Medicare and Medicaid Services (CMS) announced on Thursday. “CMS has issued guidance to Medicare Part D plans stating that ...
The Rev. Jeffrey Jackson: Cover anti-obesity drugs for older people in Wisconsin
Wisconsin State Journal· 1 day agoAs a Middleton alderman and reverend, one of the issues I hear most from my neighbors and...
JD Supra: The ACA 1557 Final Regulations: Plans and Plan Sponsors as Covered Entities
JD Supra· 4 days agoIn a recent On the Subject (available here), we reported on the impact of the final rule (final rule) interpreting Section 1557 of the Affordable Care Act (ACA) on self-funded group health plans ...
Gateway - Quartz
Quartz· 7 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...